Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             118 results found
no title author magazine year volume issue page(s) type
1 Analysis of PArkin Co-Regulated Gene in a Taiwanese–Ethnic Chinese cohort with early-onset Parkinson's disease Taylor, Juliet M.
 2009
 15 Supplement 3 p. 417-421
5 p.
 article
2 Avances en tratamiento medico de la enfermedad de Parkinson [Advances in the medical treatment of Parkinson's disease] Chaná, Pedro
 2009
 15 Supplement 3 p. S22-S25
4 p.
 article
3 Community-based rehabilitation for Parkinson's disease: From neurons to neighborhoods Hirsch, Mark A.
 2009
 15 Supplement 3 p. S114-S117
4 p.
 article
4 Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease Suzuki, Keisuke
 2009
 15 Supplement 3 p. 15-19
5 p.
 article
5 Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease Kalaitzakis, M.E.
 2009
 15 Supplement 3 p. 196-204
9 p.
 article
6 Does melatonin help save dopaminergic cells in MPTP-treated mice? Ma, Jeannine
 2009
 15 Supplement 3 p. 307-314
8 p.
 article
7 Dopamine receptor agonists in the treatment of advanced Parkinson's disease Stocchi, Fabrizio
 2009
 15 Supplement 3 p. S54-S57
4 p.
 article
8 Editorial Board 2009
 15 Supplement 3 p. i-
1 p.
 article
9 Editorial Board 2009
 15 Supplement 3 p. i-
1 p.
 article
10 Evaluation of gastric emptying in familial and sporadic Parkinson disease Krygowska-Wajs, Anna
 2009
 15 Supplement 3 p. 692-696
5 p.
 article
11 Exercise programs improve mobility and balance in people with Parkinson's disease Gobbi, Lilian T.B.
 2009
 15 Supplement 3 p. S49-S52
4 p.
 article
12 Expression QTL and regulatory network analysis of microtubule-associated protein tau gene Shen, Qin
 2009
 15 Supplement 3 p. 525-531
7 p.
 article
13 Glucosidase-beta variations and Lewy body disorders Farrer, Matthew J.
 2009
 15 Supplement 3 p. 414-416
3 p.
 article
14 High intensity eccentric resistance training decreases bradykinesia and improves quality of life in persons with Parkinson's disease: A preliminary study Dibble, Leland E.
 2009
 15 Supplement 3 p. 752-757
6 p.
 article
15 Integration deficiencies associated with continuous limb movement sequences in Parkinson's disease Park, Jin-Hoon
 2009
 15 Supplement 3 p. 682-687
6 p.
 article
16 Intrafamilial variability of Parkinson phenotype in SCAs: Novel cases due to SCA2 and SCA3 expansions Socal, M.P.
 2009
 15 Supplement 3 p. 374-378
5 p.
 article
17 Long half-life and prolonged-release dopamine receptor agonists: a review of ropinirole prolonged-release studies Onofrj, M.
 2009
 15 Supplement 3 p. S85-S92
8 p.
 article
18 Long-term effects of bilateral deep brain stimulation of the subthalamic nucleus on depression in patients with Parkinson's disease Wang, Xuelian
 2009
 15 Supplement 3 p. 587-591
5 p.
 article
19 Management of antiparkinsonian therapy during chronic subthalamic stimulation in Parkinson's disease Zibetti, M.
 2009
 15 Supplement 3 p. S76-S80
5 p.
 article
20 Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease Bardien, Soraya
 2009
 15 Supplement 3 p. 116-121
6 p.
 article
21 Motor learning in Parkinson's disease: limitations and potential for rehabilitation Nieuwboer, Alice
 2009
 15 Supplement 3 p. S53-S58
6 p.
 article
22 Multidisciplinary care for patients with Parkinson's disease van der Marck, M.A.
 2009
 15 Supplement 3 p. S219-S223
5 p.
 article
23 Non-motor symptoms in a prevalent population with Parkinson's disease in Tanzania Dotchin, C.L.
 2009
 15 Supplement 3 p. 457-460
4 p.
 article
24 O.091 Are there useful animal models of parkinsonism? Schallert, T.
 2009
 15 Supplement 3 p. S24-
1 p.
 article
25 Octarepeat changes of prion protein in Parkinson's disease Wang, Vinchi
 2009
 15 Supplement 3 p. 53-58
6 p.
 article
26 O.067 Diagnosing pre-motor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging Berendse, H.W.
 2009
 15 Supplement 3 p. S18-
1 p.
 article
27 O.019 Exercise programs improve mobility and balance in people with Parkinson's disease Gobbi, L.
 2009
 15 Supplement 3 p. S6-
1 p.
 article
28 O.036 Gaucher's disease and Parkinson's disease Wood, N.
 2009
 15 Supplement 3 p. S10-
1 p.
 article
29 O.050 Management of dementia in Parkinson's disease Burn, D.
 2009
 15 Supplement 3 p. S13-S14
2 p.
 article
30 O.033 Motor learning in Parkinson's disease: limitations and potential Nieuwboer, A.
 2009
 15 Supplement 3 p. S10-
1 p.
 article
31 Opening velocity, a novel parameter, for finger tapping test in patients with Parkinson's disease Yokoe, M.
 2009
 15 Supplement 3 p. 440-444
5 p.
 article
32 O.002 Piloting the NPF data-driven quality initiative to improve Parkinson's disease management Siderowf, A.
 2009
 15 Supplement 3 p. S1-
1 p.
 article
33 O.005 Practical strategies for sexual interventions in Parkinson's disease Bronner, G.
 2009
 15 Supplement 3 p. S2-
1 p.
 article
34 O.064 Thalamic changes in Parkinson's disease Halliday, G.
 2009
 15 Supplement 3 p. S17-
1 p.
 article
35 O.081 The role of LRRK2 in the etio-pathogenesis of Parkinson's disease Bonifati, V.
 2009
 15 Supplement 3 p. S21-
1 p.
 article
36 P2.070 Activation of striatal inflammatory mediators and caspase-3 is central to haloperidol-induced orofacial dyskinesia Bishnoi, M.
 2009
 15 Supplement 3 p. S107-
1 p.
 article
37 P2.173 Adjunctive ropinirole prolonged-release has similar effects on motor and non-motor symptoms in PD compared with carbidopa–levodopa, but delays dyskinesia onset Watts, R.L.
 2009
 15 Supplement 3 p. S137-
1 p.
 article
38 P2.204 A randomized, double-blind, placebo-controlled, delayed start study to assess safty, tolerability and efflcacy of green tea polyphenols in Parkinson's disease Chan, P.
 2009
 15 Supplement 3 p. S145-
1 p.
 article
39 Parkinson's disease dementia – A diminished role for the Lewy body Libow, Leslie S.
 2009
 15 Supplement 3 p. 572-575
4 p.
 article
40 P1.090 Attention network in AD and DLB patients: a resting fMRI study Franciotti, R.
 2009
 15 Supplement 3 p. S52-
1 p.
 article
41 P1.135 Automated Parkinson's disease motor assessment for clinical and ambulatory monitoring Heldman, D.
 2009
 15 Supplement 3 p. S63-
1 p.
 article
42 P3.049 b2 Adrenergic receptor activation induces microglial NADPH oxidase activation and dopaminergic neurotoxicity through an ERK-dependent/protein kinase A-independent pathway Qian, L.
 2009
 15 Supplement 3 p. S161-
1 p.
 article
43 P2.115 Botulinum toxin B vs. botulinum toxin A for the treatment of sialorrhea in Parkinson's disease and amyotrophic lateral sclerosis Ash, R.
 2009
 15 Supplement 3 p. S120-
1 p.
 article
44 P1.169 Cases of Parkinson's disease and movement disorders in Gobi-Altai province last 5 years Urtnasan, B.
 2009
 15 Supplement 3 p. S72-
1 p.
 article
45 P1.138 Coping in Parkinson's disease: an examination of the coping inventory for stressful situations Hurt, C.
 2009
 15 Supplement 3 p. S64-
1 p.
 article
46 P2.043 Deep brain stimulation of globus pallidus versus subthalamic nucleus for alleviating of dystonia symptoms among NBIA patients Mandat, T.
 2009
 15 Supplement 3 p. S99-S100
2 p.
 article
47 P3.080 Deep brain stimulation regulates peripheral glucose metabolism in humans: from Parkinson to diabetes Rieu, I.
 2009
 15 Supplement 3 p. S169-
1 p.
 article
48 P1.046 Depression in Parkinson's disease patients: the role of the clinical nurse specialist to improve the quality of life Lachance, L.
 2009
 15 Supplement 3 p. S40-S41
2 p.
 article
49 P3.186 Depressive symptoms and nucturnal disturbances in Bosnia-Herzegovina patients with Parkinsons's disease Sinanovic, O.
 2009
 15 Supplement 3 p. S196-
1 p.
 article
50 P1.077 Differential effects of dopamine replacement on clinical and laboratory measures of postural control in persons with Parkinson disease Foreman, K.
 2009
 15 Supplement 3 p. S48-
1 p.
 article
51 P1.221 Diffusion tensor imaging of the substantia nigra on 3 Tesla MRI: comparison of Parkinson's disease with age matched controls Kumari, R.
 2009
 15 Supplement 3 p. S86-
1 p.
 article
52 P3.178 Does quetiapine improve REM sleep behavior disorder (RBD) in Parkinson's disease? 3 case reports Carvalho, D.
 2009
 15 Supplement 3 p. S194-
1 p.
 article
53 P1.001 Double-blind controlled randomized study of the use of levetiracetam to treat tics in children and adolescents with Tourette syndrome Awaad, Y.
 2009
 15 Supplement 3 p. S29-
1 p.
 article
54 P1.224 Effects of home exercises in patients with Parkinson's disease Maki, T.
 2009
 15 Supplement 3 p. S87-
1 p.
 article
55 P2.012 Effects of Parkinson's disease rat induction on skeletal muscle morphology Loureiro, A.P.C.
 2009
 15 Supplement 3 p. S91-
1 p.
 article
56 P2.159 Efflcacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease Schapira, A.
 2009
 15 Supplement 3 p. S133-
1 p.
 article
57 P2.101 Efflcacy and safety of preladenant, a novel A2A receptor antagonist, as a levodopa adjunct in patients with moderate-to-severe Parkinson's disease Hauser, R.A.
 2009
 15 Supplement 3 p. S116-
1 p.
 article
58 P3.157 Endoplasmic reticulum stress induced hyperphosphorylation of tau by activating GSK-3β Zhengqi, F.
 2009
 15 Supplement 3 p. S188-
1 p.
 article
59 Performance on an Alzheimer-selective odor identification test in patients with Parkinson's disease and its relationship with cerebral dopamine transporter activity Chou, Kelvin L.
 2009
 15 Supplement 3 p. 640-643
4 p.
 article
60 P3.111 Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease Chan, P.
 2009
 15 Supplement 3 p. S176-
1 p.
 article
61 P3.107 Expression of Integrins αv, β3, β1 and CD44 receptor may explain the neuroprotective effects of osteopontin Ailane, S.
 2009
 15 Supplement 3 p. S175-
1 p.
 article
62 P1.063 Generalized dystonia treated with pallidal deep brain stimulation Brodacki, B.
 2009
 15 Supplement 3 p. S45-
1 p.
 article
63 P1.049 Glial monoamine oxidase participates in deamination of dopamine formed from L-dopa in a rat model of Parkinsonian striatum Sader-Mazbar, O.
 2009
 15 Supplement 3 p. S41-
1 p.
 article
64 P3.152 Glutathione is reduced in neutrophils from patients with sporadic Parkinson's disease White, L.R.
 2009
 15 Supplement 3 p. S187-
1 p.
 article
65 P2.190 Growth factors secreted by retinal pigment epithelial cells provide survival advantage to dopaminergic neurons Subramanian, T.
 2009
 15 Supplement 3 p. S141-
1 p.
 article
66 P3.128 1H-MRS after bilateral DBS of the STN in Parkinson's disease Llumiguano, C.
 2009
 15 Supplement 3 p. S180-S181
2 p.
 article
67 P3.183 Implications of deep brain stimulation on sleep disturbances for individuals with movement disorders Seibert, P.
 2009
 15 Supplement 3 p. S195-
1 p.
 article
68 P1.110 123I-/V-cu-fluoro-propyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane ([123I] FP-CIT) SPECT in cases of multiple system atrophy Gontu, V.
 2009
 15 Supplement 3 p. S57-
1 p.
 article
69 P2.132 Long-term safety and patient preference for dose frequency in patients receiving ropinirole prolonged release in early or advanced Parkinson's disease Hauser, R.A.
 2009
 15 Supplement 3 p. S125-
1 p.
 article
70 P3.097 LRRK2 diagnostic types and neuropathological forms: surgical spectrum – results comprehensive methods Echebarria Mendieta, S.G.
 2009
 15 Supplement 3 p. S173-
1 p.
 article
71 P2.119 Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 in a parkinsonian animal model Bousquet, M.
 2009
 15 Supplement 3 p. S121-S122
2 p.
 article
72 P1.193 Motor cortical excitatory plasticity is severely impaired in de novo Parkinson's disease and is improved by chronic pramipexole treatment Kishore, A.
 2009
 15 Supplement 3 p. S78-S79
2 p.
 article
73 P1.210 Negative reactions to receiving spousal care in older Parkinson's disease patients: the role of depression Loftus, L.
 2009
 15 Supplement 3 p. S83-
1 p.
 article
74 P3.066 Neuropathological characterization of posttranslationally modifled a-synuclein in PD and DLB Hilton, K.
 2009
 15 Supplement 3 p. S165-
1 p.
 article
75 P1.018 Neuroprotective effect of neuroimmunophilins against 3-nitropropionic acid induced Huntington's chorea like symptoms: possible cognitive dysfunction and biochemical and cellular alterations Kumar, P.
 2009
 15 Supplement 3 p. S33-
1 p.
 article
76 P1.104 Night time eating in Parkinson's disease, a new aspect of punding? Reddy, P.
 2009
 15 Supplement 3 p. S55-S56
2 p.
 article
77 P1.121 Non-motor symptoms in different Parkinson disease stages Bosca-Blasco, M.E.
 2009
 15 Supplement 3 p. S60-
1 p.
 article
78 P2.026 Optimizing olfactory testing for the diagnosis of Parkinson's disease Morley, J.
 2009
 15 Supplement 3 p. S95-
1 p.
 article
79 P1.179 Parkinsonian diseases neurological diseases associated with longest neuropsychiatric inpatient admissions Appel-Cresswell, S.
 2009
 15 Supplement 3 p. S75-
1 p.
 article
80 P3.108 Parkinsonism in Jamaica: a 3-year prospective study Ali, A.
 2009
 15 Supplement 3 p. S175-S176
2 p.
 article
81 P3.125 Parkinsons disease among Inuit in Greenland: persistent organic pollutions as risk factors Koldkjær, O.
 2009
 15 Supplement 3 p. S180-
1 p.
 article
82 P3.094 Pathological and clinical series in LRRK2 Parkinson's disease and ATG16L1 Crohn's disease: autophagy models comparative Echebarria Mendieta, S.G.
 2009
 15 Supplement 3 p. S172-
1 p.
 article
83 P3.005 PD patients with the E46K mutation in the alpha-synuclein gene, flve years later Gomez Esteban, J.C.
 2009
 15 Supplement 3 p. S149-
1 p.
 article
84 P3.138 Perturbation of protein thiol homeostasis through downregulation of glutaredoxin, a protein disulflde oxidoreductase, results in loss of DJ-1 through proteolysis Ray, A.
 2009
 15 Supplement 3 p. S183-
1 p.
 article
85 P1.015 Physical therapy intervention for people with Huntington disease Adwan, Z.
 2009
 15 Supplement 3 p. S32-
1 p.
 article
86 P2.053 Primary Segmental Dystonia: 4 year follow-up of 11 patients treated with GPi deep brain stimulation Sarubbo, S.
 2009
 15 Supplement 3 p. S102-S103
2 p.
 article
87 P1.152 Proflles of apathy and depression in Parkinson's disease Myerson, C.
 2009
 15 Supplement 3 p. S68-
1 p.
 article
88 P2.146 Receptor proflle of lisuride at monoaminergic receptors contributes to its high efflcacy in Parkinson's disease and Restless Legs Syndrome Latté, K.P.
 2009
 15 Supplement 3 p. S129-
1 p.
 article
89 Preface Kondo, Tomoyoshi
 2009
 15 Supplement 3 p. S1-
1 p.
 article
90 P2.187 Relationship of neighboring tissue and gliosis to a-synuclein pathology in a fetal graft to treat Parkinson disease Ahn, T.-B.
 2009
 15 Supplement 3 p. S140-
1 p.
 article
91 P2.067 Resolving mode-of-inheritance and association of PRKN with PD in a comprehensive sequence and copy-number-variation (CNV) analysis of 3800 subjects Payami, H.
 2009
 15 Supplement 3 p. S106-S107
2 p.
 article
92 P3.200 Restless legs syndrome in chronic renal failure patients under continuous ambulatory peritoneal dialysis Aksu, M.
 2009
 15 Supplement 3 p. S199-
1 p.
 article
93 Prevalence of smell loss in Parkinson's disease – A multicenter study Haehner, A.
 2009
 15 Supplement 3 p. 490-494
5 p.
 article
94 P3.022 Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats Samad, N.
 2009
 15 Supplement 3 p. S153-
1 p.
 article
95 P2.029 Reversing stimulation related cognitive-motor impairments in Parkinson's disease patients with a computational modeling approach to deep brain stimulation programming Frankemolle, A.M.M.
 2009
 15 Supplement 3 p. S96-
1 p.
 article
96 P2.098 Saflnamide as an adjunct to levodopa signiflcantly improved motor fluctuations in Parkinson's disease: a phase III, randomized, double-blind, placebo-controlled study Borgohain, R.
 2009
 15 Supplement 3 p. S115-
1 p.
 article
97 P1.166 Sleep beneflt and quality of sleep in Parkinson's disease Stavitsky, K.
 2009
 15 Supplement 3 p. S71-
1 p.
 article
98 P3.008 Spinal cord pathology in transgenic mice for Parkinson's disease Mendritzki, S.
 2009
 15 Supplement 3 p. S149-S150
2 p.
 article
99 P1.095 Spinocerebellar ataxia 3 presenting as Parkinson disease – case series Mendonça, N.
 2009
 15 Supplement 3 p. S53-
1 p.
 article
100 P1.079 Spinocerebellar ataxia types 3 and 10. Progression rate of gait ataxia in a group of 40 patients Helio, T.
 2009
 15 Supplement 3 p. S49-
1 p.
 article
101 P3.169 The efflcacy of a large-amplitude exercise approach for patients with Parkinson's disease Alvarez, M.
 2009
 15 Supplement 3 p. S191-
1 p.
 article
102 P1.032 The heterogeneous nature of Parkinson's dementia: a sub-cortical catecholamine subtype without Alzheimer's, Lewy body, or vascular pathology Frisina, P.
 2009
 15 Supplement 3 p. S37-
1 p.
 article
103 P2.084 The impact of switching to continuous release dopamine agonists on non-motor side effects Elmer, L.
 2009
 15 Supplement 3 p. S111-
1 p.
 article
104 P3.063 The unique properties of 9-methyl-b-carboline: stimulation, protection and regeneration of dopaminergic neurons coupled with anti-inflammatory effects Polanski, W.
 2009
 15 Supplement 3 p. S164-
1 p.
 article
105 P1.087 Transcranial sonography (TCS) in evaluation of patients with essential tremor (ET) Crnjakovic, M.
 2009
 15 Supplement 3 p. S51-
1 p.
 article
106 P1.207 Visual related cognitive assessments in Parkinson disease and MCI patients Li, Y.
 2009
 15 Supplement 3 p. S82-
1 p.
 article
107 P2.156 Wearing-off management in Parkinson's disease: the LEVOSTAR study two-year optional follow-up Houeto, J.-L.
 2009
 15 Supplement 3 p. S132-
1 p.
 article
108 Quantitative estimation of regional brain iron with magnetic resonance imaging Martin, W.R. Wayne
 2009
 15 Supplement 3 p. S215-S218
4 p.
 article
109 Serum inflammatory biomarkers in Parkinson's disease Dufek, M.
 2009
 15 Supplement 3 p. 318-320
3 p.
 article
110 Smoking and tea consumption delay onset of Parkinson's disease Kandinov, Boris
 2009
 15 Supplement 3 p. 41-46
6 p.
 article
111 Spinocerebellar ataxia 8: Variable phenotype and unique pathogenesis Gupta, Amitabh
 2009
 15 Supplement 3 p. 621-626
6 p.
 article
112 Striatal spine plasticity in Parkinson's disease: pathological or not? Smith, Y.
 2009
 15 Supplement 3 p. S156-S161
6 p.
 article
113 Subthalamic nucleus stimulation applied in the earlier vs. advanced stage of Parkinson's disease – Retrospective evaluation of postoperative independence in pursuing daily activities Yamada, Kazumichi
 2009
 15 Supplement 3 p. 746-751
6 p.
 article
114 The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients Go, Criscely L.
 2009
 15 Supplement 3 p. 655-659
5 p.
 article
115 The prognosis of fixed dystonia: A follow-up study Ibrahim, N.M.
 2009
 15 Supplement 3 p. 592-597
6 p.
 article
116 Treatment of dysautonomia associated with Parkinson's disease Mostile, Giovanni
 2009
 15 Supplement 3 p. S224-S232
9 p.
 article
117 Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency Zigmond, Michael J.
 2009
 15 Supplement 3 p. S42-S45
4 p.
 article
118 Update on models of basal ganglia function and dysfunction DeLong, Mahlon
 2009
 15 Supplement 3 p. S237-S240
4 p.
 article
                             118 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands